Sarcoidosis in Neurosarcoidosis with Peripheral Facial Nerve Palsy
Peripheral facial nerve palsy is the most common neurologic manifestation of neurosarcoidosis. When sarcoidosis presents in this way, a targeted first-line approach is available — one directed at restoring facial nerve function within a defined timeframe.
Clinical Scenario
Sarcoidosis with nervous system involvement (neurosarcoidosis) presenting as peripheral facial nerve palsy — a distinct neurologic subset that warrants its own management strategy.
Treatment Approach
The first-line protocol for this presentation involves an oral corticosteroid course, structured around the clinical response of the affected nerve.
The specific regimen — including which agent, the starting approach, the taper schedule, and the criteria for discontinuation — is detailed in the full protocol below.
Clinical goal: Resolution of facial nerve weakness within 1–6 months.
References
- The most common neurologic manifestation of neurosarcoidosis is peripheral facial nerve palsy.
- A limited course of prednisone 20-40 mg daily is recommended for these patients.
- The dosage should be tapered over 1-6 months and can be discontinued if weakness resolves.
View source ↗